Skibo EB - Search Results

1

Studies of pyrrolo[1,2-alpha]benzimidazolequinone DT-diaphorase substrate activity, topoisomerase II inhibition activity, and DNA reductive alkylation.

Skibo EB, Gordon S, Bess L, Boruah R, Heileman MJ. Skibo EB, et al. J Med Chem. 1997 Apr 25;40(9):1327-39. doi: 10.1021/jm960546p. J Med Chem. 1997. PMID: 9135030

2

Structure-activity studies of benzimidazole-based DNA-cleaving agents. Comparison of benzimidazole, pyrrolobenzimidazole, and tetrahydropyridobenzimidazole analogues.

Skibo EB, Islam I, Heileman MJ, Schulz WG. Skibo EB, et al. J Med Chem. 1994 Jan 7;37(1):78-92. doi: 10.1021/jm00027a010. J Med Chem. 1994. PMID: 8289204

3

A comparison of the cytotoxic and physical properties of aziridinyl quinone derivatives based on the pyrrolo[1,2-a]benzimidazole and pyrrolo[1,2-a]indole ring systems.

Boruah RC, Skibo EB. Boruah RC, et al. Among authors: skibo eb. J Med Chem. 1994 May 27;37(11):1625-31. doi: 10.1021/jm00037a013. J Med Chem. 1994. PMID: 8201596

4

A comprehensive study of the active site residues of DT-diaphorase: rational design of benzimidazolediones as DT-diaphorase substrates.

Suleman A, Skibo EB. Suleman A, et al. Among authors: skibo eb. J Med Chem. 2002 Mar 14;45(6):1211-20. doi: 10.1021/jm0104365. J Med Chem. 2002. PMID: 11881990

5

Chemistry of the pyrrolo[1,2-alpha]benzimidazole antitumor agents: influence of the 7-substituent on the ability to alkylate DNA and inhibit topoisomerase II.

Zhou R, Skibo EB. Zhou R, et al. Among authors: skibo eb. J Med Chem. 1996 Oct 11;39(21):4321-31. doi: 10.1021/jm960064d. J Med Chem. 1996. PMID: 8863809

6

Design of highly active analogues of the pyrrolo[1,2-a]benzimidazole antitumor agents.

Craigo WA, LeSueur BW, Skibo EB. Craigo WA, et al. Among authors: skibo eb. J Med Chem. 1999 Aug 26;42(17):3324-33. doi: 10.1021/jm990029h. J Med Chem. 1999. PMID: 10464019

7

Inhibitors of topoisomerase II based on the benzodiimidazole and dipyrroloimidazobenzimidazole ring systems: controlling DT-diaphorase reductive inactivation with steric bulk.

Schulz WG, Skibo EB. Schulz WG, et al. Among authors: skibo eb. J Med Chem. 2000 Feb 24;43(4):629-38. doi: 10.1021/jm990210q. J Med Chem. 2000. PMID: 10691689

8

Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: new reductive alkylating DNA cleaving agents.

Islam I, Skibo EB, Dorr RT, Alberts DS. Islam I, et al. Among authors: skibo eb. J Med Chem. 1991 Oct;34(10):2954-61. doi: 10.1021/jm00114a003. J Med Chem. 1991. PMID: 1920349

9

Pyrrolo[1,2-a]benzimidazole-based aziridinyl quinones. A new class of DNA cleaving agent exhibiting G and A base specificity.

Skibo EB, Schulz WG. Skibo EB, et al. J Med Chem. 1993 Oct 15;36(21):3050-5. doi: 10.1021/jm00073a002. J Med Chem. 1993. PMID: 8230090

10

Pyrrolo[1,2-a]benzimidazole-based quinones and iminoquinones. The role of the 3-substituent on cytotoxicity.

Schulz WG, Islam I, Skibo EB. Schulz WG, et al. Among authors: skibo eb. J Med Chem. 1995 Jan 6;38(1):109-18. doi: 10.1021/jm00001a016. J Med Chem. 1995. PMID: 7837221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters